Axis Vaccine Policy Causes Culture Crisis

By John Honovich, Published Feb 17, 2022, 08:33am EST (Info+)

While Axis and its employees pride themselves on Axis' culture (see our 2021 report), this is facing a crisis over increasing pressure over non-vaccinated employees in the last year.

IPVM Image

Though we first reported about the Axis vaccine requirement earlier this week, new information, from discussions with those close to Axis, show that this conflict grew throughout 2021 and that numerous employees are impacted.

In this note, we examine how restrictions increased and how many potential employees are impacted.

** ***** ** **** ******, **** Americas ****** *** ************ ********* **** having "******** ***********" ******* ** **** offices, ** *** ***** ***** *****:

IPVM Image

**** *** * ***** ********* ****** as **** **** ******** ********* **** in ***** ***** ***** (***, **, etc.). ** **** ****** ***** ***** customers, ** ************* ********** *** *********' ability ** ** ***** ****.

********, *** ****** *** *** ********** of ******* ********* *** *** ****** requiring ******** ** ** ********** ** even ** *** ********* **** ************ themselves. **** *****, **** */*** ** those ** ***** *** *** *** vaccinated ** *** ** *** **** than */*** ** ***** **-** *** unvaccinated,*** *** **** ******.

**** *****, **** **** ** ***** to ***+ ********* *** *** *** yet ******** ***** "complete vaccine record" telling them they "cannot travel" (including Axis annual kickoff) and that management thinks this is "best to protect" the unvaccinated, as the email excerpt below shows:

IPVM Image

Axis ********

**** ********* ** **** ***** *** ban ** ************ ********* ******** *********:

** ***** ** *** **** ** caution *** *** **** ** *** staff, ******** *** ********* ** ********** that *** ****** ********* *** ******** customers *** ****** **** **********. ************, we **** **** ******** ******* **** of *** *********, ******** *** ****** had *** **** ***********, *** ** was *** **** *** ** ******** the ****-******** ***** *** *********** ***** often ****** ** ******** *** ********.

**** **** **** **** **** ***** 10 ********* *** ********:

******* *** ****** *** ******** **** together ** ** *** ***** ** Axis *******. ** ***** ******* *** employee’s ******** ** *** ** **********. We ******* *********** *** ****** ********* whose ********* ********* ******* ************* ** customer *** ******* ***********, ******** ******, and ******** ******. ** ******** ** encourage *** ************* ** ** *** employees ******** ** **** ****** ** consider **** ********* ****** **** **** do *** ******* ***********.

** **** ***** **** * ****** of **** ********* **** ***/** *** going ** ****** **** **** *** we *** *** ******* ** *** total ******. ** **** *** ****** how **** **** ********* **** *** vaccine ***** ****** ** ***** ***** or *** **** ********* **** ******** from *** ******* ***********.

*** ***** ** *******,** **** *********, *** *** **** ******** ***** will ** ******** ** ** **********.

Culture ********

**** *** ****** *********** ******** ******* Axis *********, ****** ********* *** ********* to ***** ********, ***** **** ***** jobs *** ********* ** ***** ****.

*** ****** **** ********, *** **** 14 ****** ***,******* *. ***************** ********** ********** **** ************ ** "**********" ********* *** **** his ****** **-******* *** "***** ****** to **** ************** *********":

IPVM Image

******* ****** ***** ** *** ********* described **** ** * ********** ******* those ** **** ********** ** ************* and **** ********* ********** *** ***, many *** *** ********** *** **** of ****** ***** ****:

********** ** ********** ******** *** *********** about *** ********, ***** ** **** definitely * ********** ******************'* ********** ** ********** *** **** of *** **** ** *** ********. There *** **** * *** ** angst **** ** ***-**** ******* ********* the ********. **** ****** ******* *** got *** *** ** ***** ** maintain ***** ****** ******- *** ** **** ********.

******* **** ****** **** ******* ** the ********** ** ******* *** **** Axis *** *** ***** ** ** its ****** *** *******:

******** ****** *** ******** ***, ****** as ***, *** ****** ****. *** can *** **** ****** ** **** story ** *** *** ***, *** by ******** *** ******** *** ******** classes ************** *********, **** **** *****'* ***** like ****** ** ***.

*** **** ***** ************, "*******" *** "values" *** ****** **** *** **** to ***** ** *** ******* ** profit. *** *** *****, ************ **** *************, **** **** **** really ******** ** ******** ********** ****** **** *******, ***** ***** the ********** **** *** **** ******* policy **** **** *********.

******

**** ******* ************ ********** ************* ****** ************* ****** ******** *** Axis **** *** **** ****-****. *** vaccine ***** ** *********** **** ******* and ******* **** ** **** *** many ** ** ***** ** ***** policies. ****, *** ********** ******* ********* (delays ** * ****** ** **** are ******** ********) **** ******* *** type ** ****** *** **** **** the ******* *** ******** ***** ***** before.

Comments (104)

Undisclosed End User #1

02/17/22 01:41pm

***** ******, *****… ******?

IPVM Image

Agree: 4
Disagree
Informative
Unhelpful
Funny: 36

John Honovich

IPVM | In reply to Undisclosed End User #1 | 02/17/22 01:42pm

* *** * *** **** ********* about ******* ********** "***********":

IPVM Image

Agree: 4
Disagree
Informative
Unhelpful
Funny: 15

Undisclosed End User #1

In reply to John Honovich | 02/17/22 01:44pm

**** *****, *******.

Agree: 2
Disagree
Informative: 1
Unhelpful
Funny: 20
Avatar

Ari Erenthal

Chesapeake & Midlantic
In reply to Undisclosed End User #1 | 02/17/22 01:45pm

**** ******** **** ******** * *****.

Agree: 7
Disagree
Informative
Unhelpful
Funny: 5

Undisclosed Integrator #12

In reply to Ari Erenthal | 02/18/22 12:24am

**** *** **** ** ** ** NFT.

Agree
Disagree
Informative
Unhelpful
Funny: 2

Anthony Beland-Lavoie

IPVMU Certified | In reply to John Honovich | 02/17/22 01:57pm

**** **** **** ******* ******* ******* for ****. **** ***** ** **** Tony ***** ** *** ********** ****** their **********.

Agree
Disagree
Informative
Unhelpful
Funny: 3

Undisclosed Integrator #3

In reply to Anthony Beland-Lavoie | 02/17/22 02:52pm

** **** ** ***** **** ******** and *** ******* ***** ******* **** cameras ********.

Agree: 3
Disagree
Informative
Unhelpful
Funny: 4

John Honovich

IPVM | In reply to Anthony Beland-Lavoie | 02/17/22 06:06pm

**** **** ******* ******* ******* *** them

*** **** **** * ******* ******* America *** **** ********, ***** *** evidently ** ** **** ******...

Agree
Disagree
Informative
Unhelpful
Funny: 3

Undisclosed Integrator #10

In reply to John Honovich | 02/17/22 10:56pm

*** ***** *** ******.

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed End User #2

02/17/22 02:36pm

* ***** ******* ****'* *** **** thing ****'* ***** ** ** ** short ****** *** **** ;*

(*'** *** ****** ***)

Agree: 3
Disagree: 1
Informative: 1
Unhelpful
Funny: 13

Undisclosed End User #1

In reply to Undisclosed End User #2 | 02/17/22 04:40pm

***-*** *****... ***

Agree: 1
Disagree: 1
Informative
Unhelpful: 3
Funny

Undisclosed End User #2

In reply to Undisclosed End User #1 | 02/18/22 12:38pm

************** *********? ** *** *** **** jealous ** ** ****** ** *** Church *** *** **** *****?

Agree
Disagree
Informative
Unhelpful: 1
Funny: 4

Undisclosed End User #1

In reply to Undisclosed End User #2 | 02/19/22 02:10am

**** **** ****** *********?

*** ********* ** ***. **'* **** dumb.

*** ***** ***** ** ** ******* made * ******* ******* ***** ***-******, Ken's *** *****'* ***** ************ ******* how ********* ** ** ** **** about ****** *****.

Agree
Disagree: 1
Informative
Unhelpful: 1
Funny

Anthony Beland-Lavoie

IPVMU Certified | In reply to Undisclosed End User #2 | 02/22/22 01:44pm

*** ****** ** *** **** ***** sounds **** ********* ******** *** ** the ******* ******** ****.

Agree
Disagree
Informative
Unhelpful
Funny
Avatar

Carl Stoffers

IPVMU Certified | 02/17/22 03:54pm

**** *** ******** ** ***** **** earlier **** ***** ** ***** **** provided ********* ***** ******* ********* ***********, including **** ***-********** ********* ******:

IPVM Image

**** ****** ****** **** *** ***** for ************, *** **** ***** ** find ** ********* ******** *** ************ employees.

Agree
Disagree
Informative: 11
Unhelpful
Funny

Undisclosed Manufacturer #4

In reply to Carl Stoffers | 02/17/22 04:54pm

** ***** ** **** ** *** those ****** ******* ********* *********. * know * *** ****** ****** **** who **** *******, **** *** ******* me ****'** **** ** **** ******.

** ******* **** *** ** ******* a ******** **** ******** ***** ** the *** ******* ** ***** ******** ultra ****-**** ****** ** ****** ******** and ********** ** ** ******* ** the ***. ***** **'* **** ** spend *** ******** ******* **** ********* that ****** *** ********** ** ******* and ****** - *** ********** **** allowed **** ** ******* ** *** first *****.

Agree: 7
Disagree: 6
Informative: 4
Unhelpful: 6
Funny: 2

Undisclosed Integrator #5

In reply to Undisclosed Manufacturer #4 | 02/17/22 06:55pm

**** * ** **** ***** ** zero **** ** *** *** ** non ************* ** ******* **** ***** we **** ***** ** **** ********?

Agree: 1
Disagree: 1
Informative
Unhelpful: 1
Funny: 3

Undisclosed End User #1

In reply to Carl Stoffers | 02/17/22 05:20pm

******* * ********* ********* *** ******* accommodation.

**** ****** *** ** ** ********** accommodations.

Agree: 2
Disagree: 7
Informative
Unhelpful: 2
Funny

Undisclosed End User #1

In reply to Undisclosed End User #1 | 02/17/22 07:13pm

********? **'* * ****. ********** ************** cannot ** ****** ** *** *.*. Disagree *** *** ****.

***** **** ********* *** ******* ********** are ********* ** *** ************ ** United ****** ** ******* **** (***. 1992), ***** *** ** *** ***** Rights *** ** ****, *** ***** Amendment, *** **** ******** ****** ** the ***** *********, *** ****** *********, The ********** *********, *** ***** ********** Clause ** *** ********** *********, *** most **** *********** ***** ***** *** state.

** *** ****'* *** **** ******** on ****** ** ********* *** ********* accommodations, *** ****'* *** **** ******.

********... ***. ******* **** ** **** regret. *** **** **** **** *** is ** **** **** ******** **** is ********* ****.

Agree: 7
Disagree: 3
Informative: 2
Unhelpful: 2
Funny: 2

Undisclosed Manufacturer #7

In reply to Undisclosed End User #1 | 02/17/22 07:32pm

***** ***********?

**** *,*** *** ******* ***** *** refusing ***** *******

Agree: 2
Disagree: 1
Informative
Unhelpful: 1
Funny

Undisclosed End User #1

In reply to Undisclosed Manufacturer #7 | 02/17/22 07:43pm

*** **** *** **** ** **** for *** ** **********. * ************ mentioned *********** *** ************** ******* ** religious *** ******* **********.

***** *** ********* **, *** **** of *** *,*** ******** ********* ** medical **********?

Agree: 2
Disagree: 1
Informative
Unhelpful: 1
Funny

Undisclosed Manufacturer #7

In reply to Undisclosed End User #1 | 02/17/22 11:03pm

***** **** ** *** * **** a **** **** *************. ** ******, they ***** ****** ** *** ***** labor *****? *****? **** ***….******?

******* ***** ******* *** ********' ********* exemption ****** **** *** *******

Agree: 2
Disagree
Informative
Unhelpful: 2
Funny

Undisclosed End User #1

In reply to Undisclosed Manufacturer #7 | 02/17/22 11:11pm

**** ***….******?

*** ****** ****'* **** ** ********. They ******** ** ****** **** ** comment.

******* ** *** **** * ****** not ** **** ** ***** **** states **** *** **** *** **********.

**** ******, ********* ****, ******* ************** Rights.

Agree: 5
Disagree: 2
Informative
Unhelpful
Funny

Undisclosed Integrator #18

In reply to Undisclosed End User #1 | 02/21/22 11:47pm

*************, *** ************ ** ****** ****** of ******* **** (***. ****), ***** VII ** *** ***** ****** *** of ****, *** ***** *********, *** Free ******** ****** ** *** ***** Amendment, *** ****** *********, *** ********** Amendment, *** ***** ********** ****** ** the ********** ********* **** *** ******* on *** *, ****. ***'* **** it *****'* **** **** ***.

Agree: 5
Disagree: 2
Informative
Unhelpful: 2
Funny

Undisclosed Integrator #6

02/17/22 07:25pm

** ***** ** ****...

** *** ******* ** **** *** useless...

...***'* *** ***** **** **** **** or *** ******* ** ** ***.

Agree: 10
Disagree
Informative
Unhelpful: 12
Funny

Undisclosed End User #1

In reply to Undisclosed Integrator #6 | 02/17/22 07:34pm

** ***** ** ****...

**'* ********* *** ****, **'* ***-****.

*** ******* *** **** ********** ******. Counting ********** ** * ***** ***** for *** ******* *** ****** *** data. *** *** *** **** ******** the ******* **** ******* ***** ***** the "********" *******.

*** ******* ******* *** ****** ** well. ***** *** ** ***** **** tell *** ********** ** *** **** COVID-19. ***** *** **** ***** ** Coronavirus, *** **** *** *** ******* the ****. **** **** *** **** shown ** ***** ******* ************ *** were ***** ******* ********. ******* *** been ******** ***** *** *********.

******* ***** *******. **'* ******. ** you're **** **** ****. ** ***'** really ****, ** ** *** ********.

Agree: 5
Disagree: 8
Informative
Unhelpful: 13
Funny: 1

Undisclosed End User #1

In reply to Undisclosed End User #1 | 02/21/22 06:09pm

IPVM Image

Agree: 3
Disagree
Informative: 1
Unhelpful
Funny: 5

Undisclosed Integrator #8

02/17/22 08:49pm

*********’*? ******? *** ***** ******* ** sending *** ****** ****** **** **** and ****** *********, **** ***** ** getting ***** ********* **** ************?

**’** ******* ******* **** ******* ** the **** ** ************.

Agree: 5
Disagree
Informative: 2
Unhelpful
Funny

Undisclosed #9

02/17/22 09:11pm

** ***** ** **** *** ****** of ****** ***** ** **** ******* a ******* - ********** ** *** requests *** * '********** *************' - is ***** ** * **** ****.

***** **** ********* *** ******* ********** are ********* ** *** ************ ** United ****** ** ******* **** (***. 1992), ***** *** ** *** ***** Rights *** ** ****, *** ***** Amendment, *** **** ******** ****** ** the ***** *********, *** ****** *********, The ********** *********, *** ***** ********** Clause ** *** ********** *********, *** most **** *********** ***** ***** *** state.

"**'** ******* ** ** **** ******* else" ***'* ****** *********** ********* ** any ** ***** ******.

** ****** ***** *** ***** *******.

*** ********** ****** ** ****** ** sacrosanct.

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed End User #1

In reply to Undisclosed #9 | 02/17/22 10:04pm

"**'** ******* ** ** **** ******* else" ***'* ****** *********** ********* ** any ** ***** ******.

** *** *.*., ** ******* ** if *** **** *** *** *** company ** ****** ** *********.** *** be **** ****** *** ****** ******* or ***** *** *** ********. *** Axis *********, **** ***** *** **** of *********** ************, ****** **** *** a ********* ** ******* ********* ****** have *** *** ******* ** ****** immediately. **** ****** ** *****, *** company ** ******** ** *** ** engage ** ****** ************* ***** *** employees' **************.

*** ************** ****** ** ********** *** should *** *** *********** ***** ** the ********. ** *** ******** *** prove **** **** ************* **** *********** cost, **** ************* *** ** ******. But ****** *****'* **** ******* **** to *** ********.

**** **** ** *** ******* ** that ************** *** ** ** ****** as *********** *' ****** ********** *** wearing * **** ** *** ******, during ******** ********, ***. **** ********* already *********** ***** *****, ** ***** are **** ************** **** **** ** no **** ** *** ********. ***** requests ****** ** ****** ******* ***** consequences.

* *** ** ******* ** ******, engaged ** *** ************* ************ (******** by ***), *** ******** ****** **********, masking, *** ***************** ** ** **************. These ************** *** *** ************.

** ******** *** ** *******. **** had ** ****** ***** ***** *** and ***** ********* ************* ****.

Agree
Disagree
Informative: 4
Unhelpful
Funny

Undisclosed #9

In reply to Undisclosed End User #1 | 02/17/22 10:35pm

*** **** *********, **** ***** *** talk ** *********** ************, ****** **** had * ********* ** ******* ********* should **** *** *** ******* ** notice ***********.

*****.

** *********** *** **** *** ****** of******** ***** ** **** - ***** on *** **** ****** ***** ** people *** **** **************** *********** **** ******* ***** ******* ** be.

** *** ** ******* ******** ******* that ******** *** ** ********* ************* for *** *****, **** **** * myriad ** ***** ****** **** **** can ***** ** ** ***** ******** disqualifiers **** ****'* ******* ********* - without **** ********** ******** ***** ********.

* ** **** ******* *** ************ of ******** *** ** ***** ****** protections - *** **** **** ** not *****.

Agree: 2
Disagree
Informative
Unhelpful
Funny

Undisclosed Manufacturer #11

In reply to Undisclosed #9 | 02/17/22 11:20pm

* **** * *** **** ******* for *** ********* ********* *** *** after **** ***** ******* *** ****** to *********. *** *** ******. *’* have ** *** *** *** ****** why ** *** ****** ***** **’* been * ****** ***…

Agree
Disagree
Informative
Unhelpful
Funny: 1

Undisclosed End User #1

In reply to Undisclosed Manufacturer #11 | 02/17/22 11:33pm

* **** * *** **** ******* for *** ********* ********* *** *** after **** ***** ******* *** ****** to *********

*** ***** ******* **, *** ***'********* * ********* *********. *** ****** put **** ******** ** ******. ** exemption ** ********. ******* *** ****** "approve" **** ********* ******* **'* * personal ******. ** *****'* **** **** to ** ********* ** ******. ** just *** ** ** * ******** held *********, *****, ** ******* ******.

*** **** **** ** *** ******* accommodations. *** ************* ********** ****** ** denied. ** ** ******** ** ***, enforced ** *** ****.

**** ** *** ********** *** ***** process ** * ********* ** ******* exemption, ****'* *** **** **** ******. They ****** **** *** ********'* **** when *** **** **, *** ******** has **** ********** **** *** ********.

Agree: 2
Disagree
Informative: 4
Unhelpful
Funny

Undisclosed End User #1

In reply to Undisclosed #9 | 02/18/22 03:11am

** * *********, *** ****** ** important. ** *** *** ************ *** a ***, **** ****** ******* ***** your ******* ******* *** ** ********.

*** **** ******* **** ****** ** exemption ***** *** *** *** *****. At **** ***** , ** *** are ****** **********, **’* * ********* of ***** ***.

** **** ******, ***** *** *********** with ****** ********* **** ** *** employer ******** ** ***, **** ** the **** ** *** ******* (****** of *********).

Agree: 2
Disagree: 1
Informative
Unhelpful
Funny

Undisclosed Integrator #12

In reply to Undisclosed End User #1 | 02/18/22 12:01pm

*** ****** ********** *** *** **** legal ****** **** ******** ********** ******* in **** ******?

Agree: 1
Disagree
Informative
Unhelpful
Funny: 6

Undisclosed End User #1

In reply to Undisclosed Integrator #12 | 02/19/22 02:14am

*** ****** ********** *** *** **** legal ****** **** ******** ********** ******* in **** ******?

*** ****** *** ***** ********** ** me ** *** ** *** *** Constitutional ********* ** *** ****** ******. But ****...

IPVM Image

Agree: 1
Disagree
Informative
Unhelpful
Funny: 2

Undisclosed Integrator #24

In reply to Undisclosed End User #1 | 03/01/22 02:22am

** ******* ****** **** ***** ** anything, **'* **** ******** *** * "Top ************** ********" ** ***** ****.

Agree
Disagree
Informative
Unhelpful: 1
Funny

Undisclosed End User #1

In reply to Undisclosed Integrator #12 | 02/20/22 01:29am

*** ****** ********** *** ******** ******* advice **** ***** **** ***** ** the ****** ********?

Agree: 2
Disagree
Informative
Unhelpful: 1
Funny
Avatar

Aaron Ker

02/17/22 11:23pm

IPVM Image

Agree: 1
Disagree
Informative
Unhelpful
Funny: 10

Undisclosed Integrator #13

02/18/22 03:08am

*** *********** ****** **** ******* ******* immunity ** ****** ** *******. ***** me ****** *** **** *** ******* even *** ******.

Agree: 7
Disagree: 6
Informative
Unhelpful: 1
Funny

Undisclosed Manufacturer #14

In reply to Undisclosed Integrator #13 | 02/18/22 05:23am

**** ***’* ***** *** ;)

Agree
Disagree
Informative
Unhelpful
Funny: 12

Undisclosed End User #1

In reply to Undisclosed Integrator #13 | 02/20/22 01:38am

*** *********** ****** **** ******* ******* immunity ** ****** ** *******

****** ** **** ***** ** *** 2022 ****** ******** **********. **'******** ******* ******* * **** *** T **** ********.

****:"***** ***** *** ****** ***** ** are ***** ** ******* *****-**?"

Bill *****:"Sadly, the virus itself particularly the variant called Omicron is a type of vaccine, that is it creates both B cell and T cell immunity and it’s done a better job of getting out to the world population than we have with vaccines."

Agree: 3
Disagree: 2
Informative: 2
Unhelpful
Funny

Undisclosed Manufacturer #21

In reply to Undisclosed End User #1 | 02/22/22 08:18pm

******** **** *** ***** ** ***** properly (* ****'* ***** *** ****), the **** **** *** ***** ** creating **** ***** ** ******* ******** is *** **** **** ***** ** sad ***** (**'* * ************* *********), but ****** *** **** **** **'* done * ****** *** ** ******* out ** *** ***** ********** **** vaccines ****.

*** ******* ** * ***** ** build ******** **** ******* *****-** ******, and *** ***** *** ***, *** more **** **** **. *** *** not ******* **** *****-** (** ***** that *** ******* ******* ************) **** cause ******* ******* *** *** ************ because ** **** ******** *********, *** statistically, **** ***** **** *** ***** age ***** ***** ** *** **** I've ****.

Agree: 3
Disagree: 2
Informative: 1
Unhelpful
Funny

Undisclosed End User #1

02/20/22 01:57am

*** ******* ****** ** ******.

** **** ** ****** *********** ** have ************ ** *** ************ **** COVID ******** **** ** ***** **** they ** *** ******* ********* *** increased *** **** ** *********** ** 133X.

*** *** ********, *** ** *****’* change *** *****. **** ******* **** study ** ****, *** ************* ****-******** medical *******.

** **** ** *********, *** ***'* take ** *** ** ***** **** didn’t ***********.******:*********** ***** ******** ***** ****-***** *****-** Vaccination ** *** ** **** ******** 2020 ** ****** **** | ********** | **** | **** ************://***.******************.***/****/******

Agree: 10
Disagree: 3
Informative: 4
Unhelpful: 1
Funny: 1

Undisclosed Integrator #10

02/20/22 02:06am

*** ******* ** *** ******** ** now *** **** ******** ** **, moving *******, * ********** ******, *** a ****. *** ***** *** ***** who **** *** ******** * ******* or * ********* *******, *** ***** so ******* ******* **** *** *** unreasonable *********** **** *** ********, ** any ***** ****** ** *** **** of *******, ****** ** ******* ***** of * ******** ****. ******* ****** little ***** **** *** ***.

*** ******** *** **** ******** ** reduced *** ******** ** *** ********* of *** ****** ** ** ******* to ***** ******* ******** **** ********* which *** ******* ***** *** **** of ****** *************. **** **** **** and ******** ** ** ***** ********** in **** ******. *** ***** **** and *** ** * ******** ** a ******** **** (********* ****) **** or *** *** *** ***** **** is ******* ** *********** *** *** specifically ******* ** ******** ** ********* care. ** **** *** ******** ***, anything *** ********** *** **** ** create ** ******* ********** *** ******* response **** ******* *********** **** *******, but ***** (*** ****) ************* ****** the ****** ** ****** ******** *** worlds ******** **** ********** *** *********. This **** ******** ***** ********** ******* to ******** ** ******* **** **** for *** ********* ******** **** ******** in *** **** ** ******, *****, transplants *** ***** **** *********** **********.

***, ***, ***** *** ******** ** the ******* ******* *** ***** ****. Lets *** *** **** *** ******** and **** ** ****. *** ***** is ******* ******** **** **** *** statistical ********* **** ********* *** ******** effects ** *** ******* ******. **** your *** *** ***** ******** ********* else. **** ** ** ***** ******** conversation.

******* ** **** ** *********, *** employees ******* ***** ****** **** **** their ******** *** *** ******* ******** of **** ****** **** ** **** for ** ****. **** *** *** should *** ** *** ****** *** the *****, ** ******** * *****, present, *** ***** **** ** *** company's ***** (*********), *****, *** ********* resources ** ****, *** *** ******** who ****** ******* **** **** *** a ***** ** ******* **********, ***** customers, *** ***** ********* ********* ****** either ***** *** *** *** ****** benefits **** *** ******* ******** *** them, *** ***** *** ****** *********, and ** ******.

* **** *** ****** ****** *****. My ****** ****** *** ***** ********* is *** "** *** **** *** health *********" ****** - ********** *** some ** *** *** ***** *** have ***** ******* *** ** ******. After ***** **, *** ***** ********** being ** ***** * *** ****.

(*** *** ******, * ** *** work *** ****, *** ** ****** pissed ** **** *** **** ********* reasons **** ***** ******* *******) *** I *** ***** **** ***** **** on *** ******* ******* ******* ** capable ** ******* *** ******** ***** in ** **** ** *** ****. Its *** * *** ** *** bottom ** **** ******* ******** *** news.

Agree: 9
Disagree: 10
Informative: 1
Unhelpful: 4
Funny

Carl Kristoffersen

In reply to Undisclosed Integrator #10 | 03/08/22 02:58am

* ************ *** "*****", *** **'* not * ***** ** ** ******** for.

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed Distributor #15

02/20/22 08:40pm

******* ****, "***** ******** ************" **** calling ****** "******* ****** ****** *****..."

***'* **** **** * ****** *** try ** ***** **** ******-*****:

*. ** ***, *** ****** ** receive *** ********* ********** *****, ** prevented **** ********* ****. ** *** is ********** **** *** ***** ***** be ******. *, **********, ***'* **** if ****** ****** ** **** **** once * ****, ** **** ***** they **** ****. ***** ******.

*. **** *** ****** *** ********, simply ****** ** ***** ****** ** take ************ *****, **** **** ******* carry **** **** **** *** ******* itself. ************* ** ******* *************** *** never ****** **** ******** ** *********. If **** ** *** *********, *** much ******* **** ** **? ** is **** **** *** **** ********** carry **** ** ****** & ***** which ****** *** *** ** *** other ******** ************, ********. ***** ***** is ****, ***** *** ** ** choice.

*. **'** *** *** *** ****. The ****** ** ****** *******/***** ** different, ********* ** **** ********** *******. The **** ********** ****** *** ** one **** **** ***. *** **** vs ******* *********** **** ** ** individual ********, ** ** *** ****** been.

*. ************ ********: ***** ** ***** risk ************** **** ******* **** *** risk ** ****** *******/*****, **** *****, is ************* **** *** ****** **** low ***, (*** **'*). ** *** believe ** ** ********'* ***** ** mandate ****** *** ********* *********, ** a ********* ** **********, **** * strong ******** ***** ** **** *** mandating ****** & ****** & *** standards. **** * ****** ***** **** far **** ****** **** **** **** injections *** ******* *** ****** ** adverse *********/******. ** ****, *** **** effects ** ******** ***'* ******, **** and ******* *** *** ******** *** lead ** ******* ********* *** ******** quality ** ****.

**** ** ********* ********** ****** *** would *** ****** ** ******** *** maintaining ***** *** ***** **? **** if ********* ******* ** ****** ****-****, overweight ******? *** ***** ***** **** be? *** ******, ****** *** ********* would **** **?

**** ** ****** *****: *** **** way *** ** ** *** *******, without *********, "******* ****** ****** *****..." at *** ******* ** *** **** to ** **** **** *** ******* of *** *****. *** ** *** and *'** ** **. ** **** as ******* ** ** *** *** power ** **** **** *** *****'* personal ********* *******, **** ** *** all **** ** *******. **** ** the ****** ** *** ********** *********. They ******* ** **** **** *****, allowing ** ** ***** ** **** unites, ****** **** ******* **. ***'* restore *** ****-****** ********** ** ******* privacy *** ********** ********. **** *** divisive ************* *** ****** **** *** need ** **** **** ******* ****. Peace.

**** ****: ** **'* *** ** to ***** **** *********' ******* ******* and ******* ****** *** ********* *******, as ********** ** **********, **** *** covid **** ***** **** ** **** the *********.

Agree: 15
Disagree: 3
Informative: 6
Unhelpful: 1
Funny

Undisclosed Integrator #13

In reply to Undisclosed Distributor #15 | 02/20/22 08:56pm

**** *** *** ** ** *** best ***** ** *** ******* *'** read ***. ** ******* ******** ******* of ****. *** ****** **.

Agree: 7
Disagree: 1
Informative
Unhelpful
Funny

Undisclosed Distributor #16

In reply to Undisclosed Distributor #15 | 02/20/22 11:46pm

********* **** ********* ** #* "** is **** **** *** **** ********** carry **** ** ****** & ***** which ****** *** *** ** *** other ******** ************, ********."

** *** **** * ****** ** site **** ********* ** ****?

* ******* **** ****** ***** ** reference ***** **** *** ****** ** support **** *********:*** ***** ******** ****** ******* ** mRNA ******** **** ********* ********

Agree: 2
Disagree: 1
Informative
Unhelpful: 3
Funny

Undisclosed End User #1

In reply to Undisclosed Distributor #16 | 02/21/22 01:56am

*** ******* *** ******* ******* *** Prevention (***) *** *** *.*. **** and **** ************** (***), ****** *** latest ******* ** ******** **:

******* ******* ******: *,***,***

******* ******* ****************: ***,***

******* ******** ******: **,***

******* ******* ****** ******: ***,***

******* ******* ****** ****: ***, ***

******* ******* **** *****: **,***

******* ******* ***********: *,***

******* ******* ************: *,***

******* ******* ***** *******: **,***

******* ******* ***********/************: **.***

******* ******* *********** ********: **,***

******* ******* ****************: *,***

******* ******* ********: **,***

*** ***** *** **** *** ******** events.

******:*********.***/*******/*****.***

Agree: 2
Disagree: 6
Informative: 2
Unhelpful: 2
Funny

John Honovich

IPVM | In reply to Undisclosed End User #1 | 02/21/22 02:08am

***:***: ******** ******* ****** ******** ***** COVID-19 *********** ******* ***. **, ****

**** **** *** ******* ***** ** COVID-19 ******** **** ************ ** *** United ****** **** ******** **, ****, through ******** **, ****. ****** **** time, ***** ******** **,*** *********** ******* of ***** (*.****%) ***** ****** *** received * *****-**

Agree: 5
Disagree: 1
Informative: 1
Unhelpful
Funny

Undisclosed End User #1

In reply to John Honovich | 02/21/22 02:11am

*************** ****** ********...

***************** ********* *** **** * ***** for *** **** *** *****.

Agree: 2
Disagree: 2
Informative
Unhelpful: 2
Funny

Undisclosed Distributor #16

In reply to Undisclosed End User #1 | 02/21/22 04:02am

*** ***** ******** ******* ***********, *** causative **** ****-***********.

Agree
Disagree
Informative
Unhelpful
Funny: 1

Undisclosed Distributor #16

In reply to Undisclosed Distributor #16 | 02/21/22 04:04am

.

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed End User #1

In reply to Undisclosed Distributor #16 | 02/21/22 05:29am

IPVM Image

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed Integrator #13

In reply to Undisclosed Distributor #16 | 02/21/22 12:58pm

**** ***** *** **** *** ** in ***********:

***** ******* *** *****-** ******** ******* 01/14/2022 – ***** ********

* *** ******* **** * *** that *****... *** *** *** ** to *** ***** ***** ******** *** generate *** **** *****. ***** ** is **** **** ** **** *** prove ********* - *** **** ***** be **** *** *** ** *** other ********. ********* ** ***** ****. And ** ****** ***** *** ************ injuries - **** **** ***** **** it **** *** ********. *** ******* at **** ***** *** ****** ** least ********* **** ** ***** ********** liberty ** ****** ******* ********* *****.

*** ** **#** ***** ******* *** - ** **** ** **** ***** insurance *****, ****** ** *** *** to ** ********** ** *** *********. These *** ********* *******. ***** ** the ********** **** ** **** ** diabetes **** **** *** *** - and **** ** ******* * ****-***** disease.

Agree: 2
Disagree
Informative: 1
Unhelpful
Funny

Undisclosed End User #1

In reply to Undisclosed Distributor #16 | 02/21/22 11:11pm

********* **** ********* ** #* "** is **** **** *** **** ********** carry **** ** ****** & ***** which ****** *** *** ** *** other ******** ************, ********."

IPVM Image

Agree: 4
Disagree: 2
Informative: 1
Unhelpful
Funny

Undisclosed Distributor #16

In reply to Undisclosed End User #1 | 02/22/22 12:11am

********** *** ******** ***** **** ***** is **** ***.

Agree: 1
Disagree
Informative
Unhelpful: 3
Funny: 1

Undisclosed End User #1

In reply to Undisclosed Distributor #16 | 02/22/22 12:27am

********** *** ******** ***** **** ***** is **** ***.

****'* ****. ** *** **** ******** when *** ***'* **** ******** ******* for ** ************ ******* ******* *** government ********** ***** ***** ******* ** data ******* ** *** ****** **** that ****, **** **** *** ****** would *** **** **** ************ *******?

*** *.*.*. ***’* ********** ***** ******** of *** ***** **** ** ******** - *** *** **** *****

IPVM Image

Agree: 4
Disagree: 1
Informative: 2
Unhelpful
Funny

Undisclosed Distributor #16

In reply to Undisclosed End User #1 | 02/22/22 01:24am

*** ********* **** ** **** ** supporting **** ********** ************** ***** * vaccine **** ** ****** **** *** effective. ** ** *******, *****'* ** point ******* ******* ***** **** ****** that **** ********** **** *** **** pundits ******** ********.

Agree: 2
Disagree: 4
Informative
Unhelpful: 3
Funny

Undisclosed End User #1

In reply to Undisclosed Distributor #16 | 02/22/22 02:50am

*** ********* **** ** **** ** supporting **** ********** ************** ***** * vaccine **** ** ****** **** *** effective. ** ** *******, *****'* ** point ******* ******* ***** **** ****** that **** ********** **** *** **** pundits ******** ********.

*****, ***, *** *** ******* *********, cannot *** **** *** ********* **** experimental ******** **** **** ****** ****. Not ** *******, ******* *** ********* in ****** **** **** *** **** the ***** *** **********.

******, * ***'* ***** ** ****** Fox ****. * ***'* **** * talking **** ********** *** ******* ** explain ******** ** **. * **** details ** *********** *********, ******, *** audio ** ********* *** *********. * get *** ******** ** ** *********** from ******* *** ***** .*** *******, hearings, **********, **** ********* *** ********* via *** *** *** ****** *** CSPAN *** ******* **********.

* ******** ** ******* * **** to * ************* ****-******* ********* ********* on *** *** *** ******* **** because * ******* ***'** ****-******* *** you *****, ******* *** *****, ********* the ***** ** "*** ****!". ** assumption *** ***% *******.

* **** *** **** **** **** here. ******* ** ******** *** *****, the **** ******* ** **** ******** is *********** ** "***** ***********" *** "racism".

**** ***********.

Agree: 3
Disagree: 3
Informative
Unhelpful: 3
Funny

Undisclosed Distributor #16

In reply to Undisclosed End User #1 | 02/24/22 06:11pm

*** ******* ******** ** **** * partisan ** *** *** ****** **** her *** ******, ***** ** **********.

*** **** *** *** ***** ***** the **** ** **** ** ***********, but *****, **** ** **** **** not ******* * ********* ** ******** outcomes - *** ** **** **** into ********** ***********.

********* *** *** ********* ** *'** stop *****. **** ***, *** **** health.

- **** **** * **** ****** sense, ******** ** *** ********** ****** and **********.

Agree: 1
Disagree: 2
Informative
Unhelpful: 1
Funny

Undisclosed End User #1

In reply to Undisclosed Distributor #16 | 02/24/22 07:34pm

*** *****, **** ** **** **** not ******* * ********* ** ******** outcomes

*** **** ** ******* ******* ******** outcomes.

******* "**********"? ***.

****'* * **** ****** **** *** has *** *** ** ********* ** support ***/*** ********.

Agree: 2
Disagree
Informative
Unhelpful
Funny

Undisclosed End User #1

In reply to Undisclosed Distributor #16 | 02/22/22 03:16am

**** ********** ************** ***** * ******* that ** ****** **** *** *********

**** **** ***** **** **'* "****** to ** **** *** *********" ** you?

**** *** ****: "************ ******** ****** ********** ******* ** multiple ***************** *** *******...

***** ** *** *** **** ***********?

IPVM Image

******:*** ******* *****-** *********** ******** *******

Agree: 2
Disagree
Informative
Unhelpful
Funny

Undisclosed Distributor #16

In reply to Undisclosed End User #1 | 02/24/22 05:27pm

************ ********** **** **** ******** *********** medical ************ *** *********** **** *** vaccines *** **** *** *********. * never **** **** **** ******* ****. The *********** **** ** ********* ** vaccination *** ******** ********, ********* ********* of ***********, ******** *******, ***. ****** be ******* ** ******.

Agree: 1
Disagree: 3
Informative
Unhelpful
Funny

Undisclosed Integrator #13

In reply to Undisclosed Distributor #16 | 02/24/22 06:12pm

*** ******* **** *** "************ ****" showing ** ** "**** *** *********" is **** ** ******* ** **** accurate **** *** **** ** *** see **** *** ******. ** ****** that *** *****-******* ****** ******** ******** wants ** **** ******** *********. ** assume **** *** ***** ****** ******* most ******* ******** - *** ** course ** **** ** **** ******* a ******** ** ****. *** **** you **** ******** ******* **** **** coming ***:*****://*******.***/********,

** *** **** *** ******* *** scientifically ****** ** ** **** **** little **** ** ** ******** ********* if *** ******* **** "********* = scientific *****". *** ** ****** **** would **** **** **** ** ****** still ** ***** ************ *** **********.

** **** **** **** ** **** the **** ****** ** ******* ******** - ** **** ***'* **** *** and ***** ** ** **** ********* of ******** ******* ********* ****** ************* and *** *****.

Agree: 2
Disagree
Informative
Unhelpful
Funny

Undisclosed Integrator #10

In reply to Undisclosed End User #1 | 02/22/22 08:43pm

* ***** ***** **** *** ********** is *** ***** ********* ** ******** on * ******** ** **** **** impacts **** ** ****** **** *** general ****** **** ********* **** ****** them ** ***** *** ***/** ** deaths ****. *** ****** **** ** it ******.

* **** ******* *** *********** ******** all *** **** **** ********* ** them ** *** ******** *** ***** manufacturers **** ******, *** ********* ******* on * *** ***.......

................** ****.........

*'* *** * **** ** ** arm ****** *'* *** ** * plane **** *** *** ***** ******, so *** ** ***** * ****** standard?

Agree: 1
Disagree: 1
Informative
Unhelpful
Funny: 1

Undisclosed End User #1

In reply to Undisclosed Integrator #10 | 02/22/22 09:30pm

*'* *** * **** ** ** arm ****** *'* *** ** * plane **** *** *** ***** ******, so *** ** ***** * ****** standard?

*** **** ********** *** *.*. ********** isn't ****** ** ***** ****** ** fly.

* ******** ** *** ************ *** nothing ** ** **** ** **********'* constitutional ****** *** *********, *****, ** ethical ******* ******* ** ****** ******* procedures.

Agree: 3
Disagree: 1
Informative
Unhelpful
Funny

Carl Kristoffersen

In reply to Undisclosed Integrator #10 | 03/08/22 03:16am

* ***** ***** **** *** ********** is *** ***** ********* ** ******** on * ******** ** ****

**'* **** * ****** ***** ***** this ****. *********** **** *** **** published. *** *** ** **** * convenient *** ** ******** *** *****.

Agree: 2
Disagree
Informative
Unhelpful
Funny

Undisclosed Integrator #10

In reply to Undisclosed Distributor #15 | 02/21/22 01:48pm

**** ***** ** **** *****. ********** a **** ****** ** ***** *** a *** *** **** ** ** dissertation. *** ** *** ** **** way.

*** ******** ****** *** *******. **** are ******* ***********, *************, *************.....** ******** to ********** ***** ***** ******* ** the *****, *** **** ******* ** almost ***** ****** ** ***** *****, (comparatively) **** *** ******* *** **** can *** ** ***** ************ ******* because **** *** *******.

*** ******** ****** ****** * ****. They **** **** ** **** **** science ** ****** ** **** ** it ***, *** **** *** ******** to **** ****** ******** *** **** triaged ** **** ** ******** *** that ***** ************** *** ***** ******* against ***** ******. ******* ** ********* science *** *** ********* ****** **** they **** ** ** ********** ***** period ** ****, **** ********* **, and **** ******** ** ******, ******, demand, *** **** ******** ** ** so **** ********** ** ************* *** the ****** ***** ******* **** ** their ****** ********. **** **** **** to **** **** ** ******** **** is ********** ******** **** ** *** long ***. "* **** ****, * dont ****, * **** ****" ** the ****** ***, "* **** ***** be **** ** ****** ** ** anything", **** **** ** *** ***** thing ** **.

*** ***** ** *** ***** ***********, any ****** *** *** **** *********** a * **** *** ****** ****** brat *** ****** ***** *** *** spinich, **** **** *** **** *** him, ***** ******* **** ** **** that ****** ****** ****.

*** ******* ******** ****** **** ***** as ** *******. ** ******* **** not ****** ** *** ***, *** person ******** **** ** **. **** not ***** *** *** ******* **** standing **** ** **. * *** eat ** ****** ***** ** ***** of ***, *** **** ****** *** health **** *** ** ******** ** any *** ** ** *** ******** health ********. ***** *** ***** *** viral ********* ****, *** ******** *** to **** **** ** **** ********* and *** ****** ** ***** *** behave, ** ******* ********, ** ******** with ***** ****** ****** * ******** is *** "* ********* ******". *** not **** * ********* ******. **** it ** ** ******** ************ ** innocent **********, ***** ** ********* ***** Axis, *** *****, ***** *** ******* Authorities **** *** ***** ** *********. I ***** **** ** *** ** spinich ******. **** ****** ** **** me *** **** *** **** ** gonna ***** ** ** ***. *** dont **** ** **** *** *******. That ***** **** **** **** **** so ****, *** **** *********** ***** to *** **. *** ********** ******* the ******* *** *** ***** ** that ***** ** **** *** **** day ***** ****** **** ******** ****** others ** ***** *** ** *****, no *** *** ***.

*** **** ** *** *** **** spinich.

Agree: 3
Disagree: 5
Informative
Unhelpful: 1
Funny: 1

Undisclosed Manufacturer #17

In reply to Undisclosed Integrator #10 | 02/21/22 01:58pm

*** ** ********** *** ********** ******* a ****** *** *** ******* **********, right?

Agree: 6
Disagree
Informative
Unhelpful
Funny

Undisclosed End User #1

In reply to Undisclosed Manufacturer #17 | 02/21/22 03:33pm

****'** ***** **********.

Agree: 3
Disagree
Informative
Unhelpful
Funny

Undisclosed End User #1

In reply to Undisclosed Integrator #10 | 02/21/22 03:36pm

*** ********** ******* *** ******* *** the ***** ** **** ***** ** work *** **** *** ***** ****** your ******** ****** ****** ** ***** way

*** **** ****** **** ****** *****. Both ********** *** ************ *** ****** the *****.

Agree: 6
Disagree: 1
Informative: 1
Unhelpful
Funny

Undisclosed #19

In reply to Undisclosed Integrator #10 | 02/22/22 02:16am

** ******* **** *** ****** ** any ***, *** ****** ******** **** to **.

**** *** **** *** ******* * lot ** ******* ******.

Agree
Disagree
Informative
Unhelpful
Funny: 6

Undisclosed Integrator #10

In reply to Undisclosed #19 | 02/22/22 08:36pm

***** *****. ***** ****.

Agree
Disagree
Informative
Unhelpful
Funny: 1

Corbin Hambrick

In reply to Undisclosed Integrator #10 | 02/28/22 06:43pm

** *** **** ** * ******* with ******* **** **** *** ** the ******'* *** ******* **** **** obesity **** ****** ******.

...*** * ***** **** *** ******* is *** ******** ******* **** ***** will ****** **** ******* **** **********....

***'* ***** ** ** ***...

***'* ***** ** ** ** *********** to *** *********** ******** ** ** the *****.

...*** * ******** **** **** ********** of ********* ******* * ****. *** I'm **** **** **** *** **** that *** *** * ***** ******* that **** ********** **** ** * virus *** *** ********* ** ** "cured" **.

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed Integrator #10

02/21/22 10:10pm

***** ********** ************* ******* *** **** of * ****** ***** ** * critical **** **** **** **** ******** the *****. *** ******* ********** ******* the *** ***** ** *** ******** argument ** **** **** *** ******* in * ****** ** ******* * vaccinated ****** ****** ** ************ ****** can ****** *** *****. **** **** do *** *** *** *** ******* point ** *** ****** *** *** not **** *** ******* ******* ** trying ** *** ****** ******,

*** ****** ****** ** ******** ****** how ******** ******* *** **** * huge ********** ** ********** ******** ********** after************ *****, ********** ** ***. ** that *****, ******** **** ***** *** everyone ** ********* *****. **. ***** ya **. *****? *** ** **** scenario, ***** *** *** ********** *** taking ******** *** ** ******** ******** medical ********* *** ***** *** *** not *** *********** *** *******, *** forcing ***** *** ***** ******* ******** care ******** **** * ********** ***** that ******* ********* *****. *** ***, let *** ********** ******* ***. ** least **** ****** ****** ** ******.

Agree: 7
Disagree
Informative
Unhelpful
Funny

Undisclosed End User #1

In reply to Undisclosed Integrator #10 | 02/21/22 10:24pm

***** *** *** ********** *** ****** pressure *** ** ******** ******** ******* resources *** ***** *** *** *** are *********** *** *******

****'* *** **** ** ***. ***'** completely ******* ******* ******** ** ** anyone *** ******** ****'* *** ********** require ******** ****.

Agree: 3
Disagree: 4
Informative
Unhelpful
Funny

Undisclosed Integrator #13

In reply to Undisclosed Integrator #10 | 02/21/22 10:40pm

***** ***** *****.

*** **** **** ********* ******* ******* and ******* ******** ** ****** ***** your ********** **** - ****** *** not ***** ******* ** ***** ***** taken ** ** ****** *** *** not *** *** *******.

*** **** ** ****** ** **** of ***** *** **** ******* ** health **** ******* ** *** ******** of ******* ******** *** ***** ** health **** **** *** ******** ****. I ******* * ****** ****** *** of **** ** ******** ***** ***** told ** **** ****** *** ********. The ******* *** *******. ******** * million ******* ***** ** *** ****. I ******* ******'* ***** ** *** what **** ****. * *** *** his ******. *** ********** *** *** his ******.

* ** *** ***** ** ***** overweight ****** **** ****** * ** not. ******** *** ********/******/******* ***** - I've *** ** ***.

*'** ** ** - *** ** you.

Agree: 2
Disagree
Informative
Unhelpful
Funny

Corbin Hambrick

In reply to Undisclosed Integrator #13 | 02/28/22 06:51pm

...***** **** *** ** ******* **...***** is *** *****'* ********

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed End User #1

In reply to Corbin Hambrick | 03/05/22 07:01am

*** ****-***-* ************ *** ******** ***** are * ****** ** *******.

****'** *** **** ******** ** ******* in ***** ******** *** *** ******* on ******* **** ******* ****.

***** *******.

Agree: 1
Disagree
Informative
Unhelpful
Funny: 2

Undisclosed End User #1

02/21/22 11:02pm

****, *********** ****** **** ***** ** *** debate **** ** ******...

******* **** **** ** ***** ********** and **** *** ****** *** *****.

**'** ***** *** ** **** ********!

Agree: 2
Disagree
Informative
Unhelpful
Funny: 2

Undisclosed Integrator #13

In reply to Undisclosed End User #1 | 02/21/22 11:12pm

* ***** **** ****** ****** ****** - **** (******* ** * *******) free **** ***** ***** ************.

Agree
Disagree
Informative
Unhelpful
Funny: 3

Undisclosed End User #1

In reply to Undisclosed Integrator #13 | 02/21/22 11:16pm

IPVM Image

Agree
Disagree
Informative
Unhelpful
Funny: 2

Undisclosed Integrator #20

02/22/22 01:43pm

**** *********, ***** *** ***** *** of *** *********, **** * ****** relative ** *** ********, ********** ** some ** *** **** *** **** the ** ******* **********. **'* ************* to ** **** **** ** ******* Axis *** ** * ******** *******. Employees ********** *** ** **** **** new ******* ***** *** **** ** doing ********. **** ** *** ***** employee ****** - ** ********* ** read ***** ********* ******* ***** *** results. *** **** *** **** ** the ********* **** ** ****** *** not ******** **** ***** ****** ***** political ********? **'* * **** ***.

Agree
Disagree: 5
Informative
Unhelpful
Funny

John Honovich

IPVM | In reply to Undisclosed Integrator #20 | 02/22/22 01:53pm

** ******** ** **** ******* ** is * ******** ***** ** * major ******* ** *** ******** ** cover *** **** ****** ** ******* unvaccinated ********* **** *** ******** ********* is ********.

* ***'* **** *** ***** *********** devolve *** **'* ** ******** ********** of *** ***** ** ******** ****** the ******** **** ***** *** ********.

**** ********* **** ** *******, ** can't **** ***** ****** ** ******** to ***** ********** *** **** ****** is ** ******** ** **** ** our ***********.

Agree: 6
Disagree
Informative: 1
Unhelpful
Funny

Undisclosed Integrator #20

In reply to John Honovich | 02/22/22 02:06pm

************ *** **** *** ******** *** many *********, ********** ***** ************* ******* the *.*., **** ********* ******** **** in ***** ** ********* **** **** was ******. * **** **** ***** were ***** ****** ********* **** ********** unvaccinated **** ********* ** **** ** coming **** *******. *** **** ** the ********* *** *** **** ****** in ********** ** ***** *********? *** this ******* *** **** ** ******** a ****** ***** ******* ****. **** is *** ** ********* ******* ** all *** *************. ** **** *****, there *** **** **** ******** **** don't ******** **. **** *** *** interest ** ******* ** ** *** of *** ******* (*** *** **** one) **** **** ** **** *******, the ******* *** **** ******* *** clearly ******* ****** ** ****** ****. As * **** ** ** ******* comment, **** ** *** *** ******** we ****** **** **** *** **** it ****** ** *** ******** ******. Companies *** **** *** ***** **** learned ** ** ********** **** ******/******* workers ** ****** ************ ** **** as ******* ******. ** ****** ******** and *********** *** ** ********** ** a ***** ** *****. ******. **********, Options. **** ** *** * ***** for ******** ******* ****** ** ** impacting **********, ***********, ** ***** ******** practices (***** ** *** ******* *** can ****** ** ****** ***** **********). Business *******, **********, *** *** ********* issues *** ***** *** ****.

Agree
Disagree: 2
Informative
Unhelpful
Funny

John Honovich

IPVM | In reply to Undisclosed Integrator #20 | 02/22/22 02:10pm

************ *** **** *** ******** *** many *********, ********** ***** ************* ******* the *.*., **** ********* ******** **** in ***** ** ********* **** **** was ******.

** ******* ***** ** ***** ************* and **** **** *** **** ******. To ** *****, ** *** *** claiming **** ** "******" *** ** the ******* ********* ** *****, **** what ** **** ****, **** ** the **** *** ***** ****. ** Hikvision ** ******** (** ***** ***** manufacturers) *** ****, ** ***** ********* cover **** ***.

**'* * **** **** * ****** of **** ********* **** **** **** this (*** **** *** ***** *** their ************), ** **** ** *** more **** "******** *******".

Agree: 6
Disagree
Informative: 3
Unhelpful
Funny

Undisclosed End User #1

In reply to Undisclosed Integrator #20 | 02/22/22 02:41pm

**** *** *** ******** ** ******* it ** *** ** *** ******* (not *** **** ***) **** **** we ****...

******* ************. ***'* **** *** ****/***** work?

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed #23

In reply to John Honovich | 02/23/22 04:57pm

** ******** ** **** ******* ** is * ******** ***** ** * major ******* ** *** ******** ** cover *** **** ****** ** ******* unvaccinated ********* **** *** ******** ********* is ********.

* ** *** **** *** ******* dodged ****, *** **** **** ******** all ********* ** ** ********** ** else... **** **** ******** ***** ******** to **** ***** ** *********** ** attend ***** ***** ** **. ** testing ******.

Agree
Disagree
Informative: 3
Unhelpful
Funny

Undisclosed Manufacturer #14

02/22/22 02:12pm

**** ** *** “********” *** ******** employees ** **** ***** ********?

Agree
Disagree
Informative
Unhelpful
Funny

John Honovich

IPVM | In reply to Undisclosed Manufacturer #14 | 02/22/22 02:15pm

** **** *** **** **** **** a ******** ********, *.*., ** ** by * ** *** *** *****.

** *********** **** ** **** **** is ********* ***** *** ***** ** firing ****** **** **** *** *********, as **** ****** ** *** ** their ******, ** ****** *** ****** to ****** ** ******.

Agree: 1
Disagree
Informative: 3
Unhelpful
Funny

Undisclosed Distributor #15

02/22/22 08:11pm

**** ** * ********* *******, *** they *** *** *** **** ********, in *** ********, ** ******** * policy ** *********** "************" *********. * suspect **** *** **** ** ******** termination ********** *** *** ** *** only **** **** ** ********** (** should ** **********) ** ****.

********* *** ****** ********* **** ********* unwanted ******* *************, ** * ********* of **********, ***, ******, ******** ********* for *** ********** ******/*****, ******** ** their *********, *** ******* ** ****.

************** ********* **** ********* ******** **********, by ****** ** *** ******, **** liability *** ******** *** ****** ****** by ***** **** **** ********. *** OSHA *******, (****** **** ** ******), has **** *********, ******* *********, **** Axis, ** ** *** ***** **** by *********** ******** *** ******* ** their *** *********. *** ****** *** drug *********, ********* *** *** ******** from ********* *** ******** ********* ** their *********, ********* **** ** ********-******** treatment. **** ******** *** ****** ********* compensable, ********** ****** *** *********’ ******** consent. ***** ***** ********, *** ****** of ***********, ** *** ******** *******.

*********, ******* ************ ****, **** * number ** ***** *******, ***** **** the ***'* ***** **** *** *** DMED ****, ************ ******* **** *******-******* injuries *** ****, ***** ******, *** not ********. *** **** ***** **** released ****** ********** ** *** **** term ******, ** ** **** ** years ****** **** **** ******* **** be *****. ** ***** **** ** now *******: *** **** **** ****** are ********, *****, ***** ** ** as ****-*********** *********. *** *********, **** Axis, ***, ************* ** ***********, ********* their *********' *************, ** ********.

Agree: 7
Disagree
Informative: 2
Unhelpful
Funny

Undisclosed End User #1

In reply to Undisclosed Distributor #15 | 02/22/22 08:30pm

******. *************, **** ******** ***** *** much ***** *** **** ****.

IPVM Image

Agree: 2
Disagree: 1
Informative
Unhelpful: 4
Funny
Avatar

David Bowling

In reply to Undisclosed End User #1 | 02/22/22 08:33pm

IPVM Image

Agree
Disagree
Informative
Unhelpful: 1
Funny: 2

Undisclosed End User #1

In reply to David Bowling | 02/22/22 08:35pm

**** *****

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed #22

02/22/22 09:26pm

"**** ** ********* ***** *** ***** of ****** ****** **** ****"

*** **** ***** ** ** ****. Let's **** ******* * ***** ***** for *** ***** **:

* ******** ***'* ******* ******** ** transmitting *** ******* (**** ***** ** end *** '*******' ******** ***** *****)

* ******* ******** ** ****** **** vax ********/ *** ****'* *** ***** considered

* *** ******** *** *** ****** only, *** ********* ****** ** **** liable.

* ** ******* ***** **** *** been ** *** ********* ** *** CDC = ** ******** *******

* ** ************* ** ************, ***** treatments (*** *****, ******* ********)

**** *** ** **** ****; *** does * ******* ******* *******? ** doesn't. (*** ***'* ****** **** *** ******** bed ******). * **** ****. * **** and **** **** ** *** ********** at ****. **** ** **** *******. There ** ** ******* ****** *** this. *** ****. **** ************.

***, ***'* *** *'* ** ***** old, *******, ******* + * ****, I *** *** '**** *** ********* and *** ******** ******, * ***'* want *** ***. *** **** ** coercing ** ** ********** *********** ** job, ****** ** ** ******, ********* my **********, ***.. ****** * *** it.

***'* *** * *** *** *** and ***. ** **** ***'* *** the ***, ** *** ******.. ***'* left? **** - *** ************ **** coerced *** ******. ******** *****'* ******** documentation (*********** / ****** ** **), it's ****** **** **** **** ** in *** ***** ******* *** *** the *****.

* **** ****. * **** *** like **** ** *** ********** ** Axis. **** ** **** *******. ***** is ** ******* ****** *** ****. Bad ****. **** ************.

********* ****:

*** ******** ****** *** *******. **** are ******* ***********, *************, *************.....** ******** to ********** ***** ***** ******* ** the *****, *** **** ******* ** almost ***** ****** ** ***** *****, (comparatively) **** *** ******* *** **** can *** ** ***** ************ ******* because **** *** *******.

* ***% ***** **** **** ********* are *******-- ***** **** ***** ***** feet ******* **** ***'* ***** **** them ** ** ****** "***** ***" end ** ******** ******** ** ****** media **** **** ***'* ****** ***** arguments **** *****. *'* **** ** see **** ********* ***** **. ***** are ** **********. ********* *** ****, consequences ******. *** ** ***, *'** do **.

**#** **** **** ***'* *** **** company ****** ****- *** ****'* ****. I'd ** *** ** ***** ********* ends ** **** * ***** ******. Axis's ****** ***** ** ******.

*** **** *** * *******..

Agree: 7
Disagree: 3
Informative: 1
Unhelpful: 2
Funny: 2

Undisclosed End User #1

In reply to Undisclosed #22 | 02/22/22 09:36pm

****** *** ****.

Agree: 1
Disagree
Informative
Unhelpful
Funny

Undisclosed Manufacturer #25

In reply to Undisclosed #22 | 03/07/22 05:37pm

***, ***'* *** *'* ** ***** old, *******, ******* + * ****, I *** *** '**** *** ********* and *** ******** ******, * ***'* want *** ***. *** **** ** coercing ** ** ********** *********** ** job, ****** ** ** ******, ********* my **********, ***.. ****** * *** it.

******** ***?........******** ** *** *** *****.

*** ************ ** *** ******** **** changed. ***** ******** *** * ******--**** can **** *** ************ *** **** in ***** ********, ** ****** *** to **** **** *** ** ******* from ***** ********.

** ***** ** ******* ** *** marketplace ** ** *** ******** *** salespeople ** **** **** ************ ** them **** **: *********** ** ****** 3 ***** ** ***** *****, ***** driving ******, ** ********, ***....

** ********* ***** ******* **** **********, onto ******** *****, *** ********* ** modes ** ********* **** *** ******* vaccination, **** *** ** **** ***** to ******* ** ** **** ***** who *** ******* ** ******* *** Axis ********?

**** ***** ****** ****** *** * choice.

Agree: 1
Disagree: 3
Informative
Unhelpful: 1
Funny

Undisclosed Integrator #13

In reply to Undisclosed Manufacturer #25 | 03/07/22 10:45pm

*** - ** *** *** ******** getting ***** ******* *** ********* * felony *** ******* ***** *** *** repeatedly ********* * ******** *** ********* don't **** ** *** **** *****? I ***'* **** **** ***** *** could ***** **** **** ***...

Agree: 1
Disagree
Informative
Unhelpful
Funny

Undisclosed #23

02/24/22 05:41pm

* ***** ***** ** * ***** integrator **** *** ********* **** ****** because ** **** ******.

Agree
Disagree: 1
Informative: 1
Unhelpful
Funny

Undisclosed Integrator #10

In reply to Undisclosed #23 | 02/24/22 07:46pm

**** ****** ** **** *******? *** Difference. ** **** **** ********** **** Products ******* ** ****, **** ***** actually **** ********* *** ** ******** would **......

**. *** **** **** **********.. ***** next?

Agree: 1
Disagree
Informative
Unhelpful: 1
Funny

Undisclosed End User #1

03/05/22 07:08am

** ******* ***, *.*. ******** ***** Mark *. ************* * *********** *** *** ** ******** *** Pfizer ******* **** *** *** **** 75 *****.

*** *********, ******** ** ***** ***, 2022, ******** ** ******** ******, “**** OF ******* ****** ** ******* ********,” which ******,*** ********* ******* *************** ***********.

* **** **** ** ********* *** be *********.

IPVM Image

Agree: 2
Disagree
Informative: 1
Unhelpful
Funny

Carl Kristoffersen

In reply to Undisclosed End User #1 | 03/08/22 03:35am

* *****'* ***** **** ***** ** his ********* **** ******.

***** *** **** ******** **** ** you, * **** **** ***** "*******" situation **********. ************ *** ** *** evidence **** **** * ***** ** the **** ** ***** ******** ** Dunning-Kruger.

IPVM Image

Agree: 2
Disagree
Informative
Unhelpful
Funny
Login to read this IPVM report.
Why do I need to log in?
IPVM conducts reporting, tutorials and software funded by subscriber's payments enabling us to offer the most independent, accurate and in-depth information.
Loading Related Reports